ARCT Q3 2023 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$217M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$43M+224.5% YoY

Gross Profit

$43M100.0% margin

Operating Income

-$19M-44.5% margin

Net Income

-$16M-37.4% margin

EPS (Diluted)

$-0.61

QoQ Revenue Growth

+312.4%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$33M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$458M

Total Liabilities

$178M

Stockholders' Equity

$280M

Cash & Equivalents

$312M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43M	$13M	+224.5%
Gross Profit	$43M	-$24M	+278.4%
Operating Income	-$19M	-$37M	+47.5%
Net Income	-$16M	-$35M	+54.0%